Markets Insider: Weight Watchers Launches Eli Lilly and Company’s New Oral GLP-1 Foundayo® Available Through LillyDirect WW International, Inc. (NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight management, announced that it is now offering access to Eli Lilly and Company’s newly FDA-approved ... Weight Watchers Launches Eli Lilly and Company’s New Oral GLP-1 Foundayo® Available Through LillyDirect Weight Watchers has established an interim office of the CEO, with Chief Financial Officer Felicia DellaFortuna and Chief Operations Officer Jon Volkmann serving as principal offi ...
Weight Watchers will not appoint an interim chief executive and will instead continue with its current "Office of the CEO" structure overseen by a committee including Chief Financial Officer Felicia ... The Globe and Mail: Weight Watchers Announces Best in Market Self-Pay Wegovy® Pricing for Med+ Members and the Launch of Preferred Subscription Pricing for Wegovy via NovoCare® Weight Watchers Announces Best in Market Self-Pay Wegovy® Pricing for Med+ Members and the Launch of Preferred Subscription Pricing for Wegovy via NovoCare® MarketWatch on MSN: Here’s how much weight-loss drugs Wegovy, Zepbound and Foundayo cost — and how to pick the best GLP-1 for you
